NLRP3 and Alzheimer disease: found (61) that the level of BHB in brain tissue and red blood cell samples of AD patients was significantly lower than that of non ad control group; BHB inhibited NLRP3 inflammasome in bone marrow-derived macrophages (BMDM) by reducing the levels of IL-1 β and caspase-1.